Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 775-777, 2004; 10.1373/clinchem.2003.025197
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frusconi, S.
Right arrow Articles by Torricelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frusconi, S.
Right arrow Articles by Torricelli, F.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:775-777.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Improvement of Low-Density Microelectronic Array Technology to Characterize 14 Mutations/Single-Nucleotide Polymorphisms from Several Human Genes on a Large Scale

Sabrina Frusconi1,1,a, Betti Giusti2,1, Luciana Rossi2, Sara Bernabini1, Filippo Poggi2, Irene Giotti1, Rosanna Abbate2, Guglielmina Pepe2 and Francesca Torricelli1

1 Unita’ Operativa Citogenetica e Genetica, Azienda Ospedaliera Careggi, Florence, Italy;2 Dipartimento Area Critica Medico Chirurgica, University of Florence, Florence, Italy

aaddress correspondence to this author at: Unita’ Operativa Citogenetica e Genetica, Azienda Ospedaliera Careggi, Viale Morgagni 85, 50134 Florence, Italy; fax 39-055-4279686, e-mail genomica@ao-careggi.toscana.it

The first 20% of the full text of this article appears below.

Large-scale human genetic studies require new technologies to genotype several samples with relative ease, high accuracy, and reasonable costs. Among the available approaches, a microelectronic array technology has been developed for DNA hybridization analysis of mutations/single-nucleotide polymorphisms (SNPs) (1)(2)(3)(4). The microelectronic array system (NanoChip® Molecular Biology Workstation; Nanogen) produces a defined electric field that allows charged molecules, such as nucleic acids, to be transported to any test site, or pad, on the electronic chip (NanoChip cartridge). Electronic-based molecule addressing can rapidly achieve a high concentration of amplicons on each pad of the cartridge. Control of temperature allows use of an optimal thermal stringency to characterize a SNP/mutation in all 100 pads of a cartridge simultaneously (5)(6). A thin hydrogel permeation layer overlies the pads; the presence of avidin or streptavidin in this layer allows the binding of biotinylated PCR products.

Although the technology is attractive, only a few protocols for its use have been published (7)(8)(9)(10)(11). We describe the development, optimization, and validation of a high-throughput method for SNPs and mutations analysis that allows performance of 1372 characterizations on each chip.

We studied samples from 150 individuals for 14 SNPs/mutations previously characterized by standard methods (restriction analysis, automatic sequencing, and allelic discrimination). Genomic DNA was isolated from peripheral blood by use of the FlexiGene DNA reagent set (QIAGEN GmbH). We analyzed 14 DNA mutations/SNPs for a total of 2100 characterizations (homozygous wild type, n = 1367; heterozygous, n = 522; homozygous mutant, n = 211). The 14 nucleotide substitutions were SNPs/mutations involving the glycoprotein Ia (GpIa), glycoprotein IIIa (GpIIIa), follicle-stimulating hormone receptor (FSHR), hereditary hemochromatosis . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. M. Gori, F. Sofi, A. M. Corsi, A. Gazzini, I. Sestini, F. Lauretani, S. Bandinelli, G. F. Gensini, L. Ferrucci, and R. Abbate
Predictors of Vitamin B6 and Folate Concentrations in Older Persons: The InCHIANTI Study
Clin. Chem., July 1, 2006; 52(7): 1318 - 1324.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.